Why Is Acadia Pharmaceuticals Falling Today? - Market Realist

Why Is Acadia Pharmaceuticals Falling Today?  Market RealistYesterday, Acadia Pharmaceuticals reported top-line results from its phase three trial evaluating Nuplazid in schizophrenia.